Expert Review of Anticancer Therapy

Promises and challenges of human papillomavirus vaccines for cervical cancer
pp. 1-5(5)
Author: Sin, Jeong-Im

New developments in targeted molecular therapies for glioblastoma
pp. 7-10(4)
Author: Wen, Patrick Y

News in brief
pp. 11-15(5)

Gefitinib for the treatment of non-small-cell lung cancer
pp. 17-35(19)
Authors: Hida, Toyoaki; Ogawa, Shizu; Park, Jang Chul; Park, Ji Young; Shimizu, Junichi; Horio, Yoshitsugu; Yoshida, Kimihide

Anagrelide: 20 years later
pp. 37-50(14)
Authors: Emadi, Ashkan; Spivak, Jerry L

The NSABP Study of Tamoxifen and Raloxifene (STAR) trial
pp. 51-60(10)
Author: Vogel, Victor G

Extreme hypofractionation for prostate cancer
pp. 61-65(5)
Author: Lee, W Robert

Cancer vaccines: will we ever learn?
pp. 67-74(8)
Authors: Johnson, Robert S; Walker, Anthony I; Ward, Stephen J

PET and PET-CT imaging of gynecological malignancies: present role and future promise
pp. 75-96(22)
Authors: Basu, Sandip; Li, Geming; Alavi, Abass

RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells
pp. 97-114(18)
Authors: Tyagi, Rajeev K; Mangal, Sharad; Garg, Neeraj; Sharma, Pradeep K

New avenues for second-line treatment of metastatic non-small-cell lung cancer
pp. 115-124(10)
Authors: Gridelli, Cesare; Maione, Paolo; Rossi, Antonio; Falanga, Marzia; Bareschino, Marianna; Schettino, Clorinda; Colantuoni, Giuseppe; Guerriero, Ciro; Nicolella, Dario; Rossi, Emanuela; Ferrara, Marianna Luciana; Palazzolo, Giovanni

Intermittent therapy in the palliative treatment of metastatic colorectal cancer
pp. 125-134(10)
Authors: Wadhawan, Anshu; Stephens, Richard; Adams, Richard

Treatment of resectable gastric cancer: current standards of care
pp. 135-142(8)
Authors: Kovoor, Philip Abraham; Hwang, Jimmy

Early development of sunitinib in hepatocellular carcinoma
pp. 143-150(8)
Authors: Zhu, Andrew X; Raymond, Eric

Acknowledgements
pp. 155-155(1)